rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Deina H. Walsh

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Bone Biologics.

In numbers

Trades disclosed
15
Buys
2
Sells
0
Bought
$10K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
4 Nov 2014
Last trade
8 Jan 2026
Last filed
21 Jan 2026

Companies traded

Where they are an officer
BBLG Bone BiologicsOfficer · Medical Devices · last 8 Jan 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jan 2026filed 21 Jan 2026BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—8,335 at $0.00filing
8 Jan 2026filed 21 Jan 2026BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—8,335 at $0.00filing
15 Jan 2025filed 21 Jan 2025BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—27,055 at $0.00filing
17 Jan 2024filed 19 Jan 2024BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—12,500 at $0.00filing
13 Sep 2023filed 14 Sep 2023BBLG Bone BiologicsMedical DevicesSEC FORM 4 Bought$5,1208,000 at $0.64filing
6 Sep 2023filed 7 Sep 2023BBLG Bone BiologicsMedical DevicesSEC FORM 4 Bought$210300 at $0.70filing
6 Sep 2023filed 7 Sep 2023BBLG Bone BiologicsMedical DevicesSEC FORM 4 Bought$4,7576,700 at $0.71filing
25 Jan 2023filed 8 Mar 2023BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—18,875 at $0.00filing
3 Jan 2022filed 28 Feb 2022BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—25,000 at $0.00filing
16 Feb 2018filed 20 Mar 2018BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—28,426 at $0.00filing
25 Mar 2016filed 31 Mar 2016BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—11,104 at $0.00filing
28 Dec 2015filed 30 Dec 2015BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—239,825 at $0.00filing
28 Dec 2015filed 30 Dec 2015BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—465,795 at $0.00filing
4 Nov 2014filed 30 Dec 2015BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code J—174,918 at $0.00filing
4 Nov 2014filed 27 Oct 2015BBLG Bone Biologicsoption or derivative · Medical DevicesSEC FORM 4 Code A—174,918 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Robert E. GagnonDirector · Director at Bone Biologics, filing Form 4 there in the last year
Bruce StroeverDirector · Director at Bone Biologics, filing Form 4 there in the last year
Siddhesh Rajendra AngleDirector · Director at Bone Biologics, filing Form 4 there in the last year
Phillip Terry Meikle IIDirector · Director at Bone Biologics, filing Form 4 there in the last year
Jeff FrelickChief Executive Officer · Chief Executive Officer at Bone Biologics, filing Form 4 there in the last year